Characteristics | OS | p | RFS | p |
---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Univariate analysis | ||||
nFAM83H/nZNF16, +/−, −/+, or +/+ (vs. −/−) | 5.463 (2.598–11.487) | < 0.001 | 4.796 (2.367–9.717) | < 0.001 |
Multivariate analysis | ||||
Age, y ≥ 65 (vs. < 65) | 3.383 (1.989–5.755) | < 0.001 | 3.249 (1.925–5.484) | < 0.001 |
TNM stage | ||||
I | 1 | < 0.001 | 1 | < 0.001 |
II | 1.897 (0.830–4.257) | 0.130 | 2.019 (0.895–4.558) | 0.091 |
III | 5.318 (2.307–12.257) | < 0.001 | 4.939 (2.219–11.459) | < 0.001 |
IV | 25.409 (8.833–73.088) | < 0.001 | 22.922 (1.988–65.772) | < 0.001 |
Histologic type | ||||
adenocarcinoma NOS | 1 | 0.008 | 1 | 0.010 |
adenosquamous carcinoma | 0.726 (0.214–2.458) | 0.607 | 0.644 (0.190–2.180) | 0.480 |
squamous cell carcinoma NOS | 35.714 (3.628–351.524) | 0.002 | 29.708 (3.079–286.603) | 0.003 |
nFAM83H/nZNF16, +/−, −/+, or +/+ (vs. −/−) | 4.808 (2.143–10.791) | < 0.001 | 4.204 (1.958–9.029) | < 0.001 |